5-Ph-IAA
CAS No. 168649-23-8
5-Ph-IAA( —— )
Catalog No. M23758 CAS No. 168649-23-8
5-Ph-IAA is a derivative of Indole-3-acetic acid (IAA), which is a plant hormone and acts as an enzyme or prodrug combination for cancer gene therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 52 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 177 | In Stock |
|
50MG | 296 | In Stock |
|
100MG | 502 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-Ph-IAA
-
NoteResearch use only, not for human use.
-
Brief Description5-Ph-IAA is a derivative of Indole-3-acetic acid (IAA), which is a plant hormone and acts as an enzyme or prodrug combination for cancer gene therapy.
-
Description5-Ph-IAA is a derivative of Indole-3-acetic acid (IAA), which is a plant hormone and acts as an enzyme or prodrug combination for cancer gene therapy.
-
In VitroWestern Blot Analysis Cell Line:HCT116 cells Concentration:1 μM Incubation Time:6 hours Result:Depleted DHC1-mAC efficiently in HCT116 cells constitutively expressing OsTIR1(F74G).
-
In VivoAnimal Model:Balb/c-nu female mice (7 weeks old; 16–20?g ) bearing mAID-BRD4 and TOP2A-mAC xenograft tumours cells Dosage:0 mg/kg, 1 mg/kg, 3 mg/kg and 10?mg/kg Administration:Intraperitoneally injection; every day; 7 days Result:Displayed significant tumour suppression of mAID-BRD4 xenografts and TOP2A-mAC xenografts.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number168649-23-8
-
Formula Weight251.28
-
Molecular FormulaC16H13NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL?(497.45 mM;?Need ultrasonic)
-
SMILESC1=CC=C(C=C1)C2=CC3=C(C=C2)NC=C3CC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.O Greco,et al. Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions. Mol Cancer Ther. 2001 Dec;1(2):151-60.
molnova catalog
related products
-
Boc-MLF
Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
-
Xylopentaose
Xylopentaose consists of five b-14 xylose sugars.
-
Cirsiliol
Cirsiliol is a selective inhibitor of 5-lipoxygenase and a competitive low-affinity ligand of benzodiazepine receptors.